Kondo Daiki, Noguchi Atsuko, Takahashi Ikuko, Kubota Hiroki, Yano Tamami, Sato Yoko, Toyono Miyuki, Sawaishi Yukio, Takahashi Tsutomu
Department of Pediatrics, Akita University Graduate School of Medicine, Akita, Akita, Japan.
Hiraka General Hospital, Yokote, Akita, Japan.
Brain Dev. 2018 Oct;40(9):760-767. doi: 10.1016/j.braindev.2018.05.003. Epub 2018 May 24.
To reveal a molecular lesion in the ZC4H2 gene in a Japanese family with arthrogryposis multiplex congenita (AMC) and intellectual disability (ID), and to characterize clinical features of patients with ZC4H2 gene mutations through a literature review.
The probands are male siblings. The elder brother is an 11-year-old boy who showed AMC and ID and frequent postprandial hypoglycemia since 3 years of age. The younger brother also showed AMC, ID, and subclinical postprandial hypoglycemia. The boys' mother also showed a minor malformation of the left toes.
Using Sanger sequencing, a hemizygous one base substitution designated c.627G > C, which is predicted to substitute asparagine for lysine at amino acid residue 209 (K209N), was identified in the siblings. The mother was heterozygous for this mutation. In silico analysis predicted K209N to be a constituent of a motif required for subcellular localization of the ZC4H2 protein in the nucleus. Transient expression studies of subcellular localization in COS-7 cells showed that compared to the wild-type protein, the transport of the mutant protein into the nucleus was inhibited, thus confirming K209N as a molecular lesion in this family. The literature reviews revealed postprandial hypoglycemia as a new clinical feature that should be considered in ZC4H2 gene-mutation disorders.
A Japanese family with AMC and ID caused by a novel ZC4H2 gene mutation was reported. Hypoglycemia should be considered one of the features in this disorder.
揭示一个患有先天性多发性关节挛缩症(AMC)和智力残疾(ID)的日本家庭中ZC4H2基因的分子病变,并通过文献综述描述ZC4H2基因突变患者的临床特征。
先证者为男性兄弟。哥哥是一名11岁男孩,自3岁起出现AMC和ID,且餐后频繁低血糖。弟弟也表现出AMC、ID和亚临床餐后低血糖。男孩的母亲也有左脚趾轻度畸形。
采用桑格测序法,在兄弟俩中鉴定出一个半合子单碱基替换,命名为c.627G>C,预计该替换会使氨基酸残基209处的赖氨酸被天冬酰胺替代(K209N)。母亲为该突变的杂合子。计算机分析预测K209N是ZC4H2蛋白在细胞核亚细胞定位所需基序的组成部分。在COS-7细胞中进行的亚细胞定位瞬时表达研究表明,与野生型蛋白相比,突变蛋白向细胞核的转运受到抑制,从而证实K209N是该家族的分子病变。文献综述显示,餐后低血糖是ZC4H2基因突变疾病应考虑的一种新的临床特征。
报道了一个由新型ZC4H2基因突变引起的AMC和ID的日本家庭。低血糖应被视为该疾病的特征之一。